Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor

Tom Maier, Julia G. Levy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

DBA/2 mice inoculated with either cells from the syngeneic P815 tumor or tumor cell membrane extracts develop T suppressor cells which suppress the in vitro generation of cytotoxic T lymphocytes with specificity for the tumor. A soluble suppressor factor with similar properties can be isolated from suppressor cell-enriched populations. It can be highly purified by appropriate immunoadsorption. Antisera to this suppressor factor raised in either DBA/2 or C57BL/6 mice can specifically absorb out suppressor factor and eliminate suppressor cells in the presence of complement. The in vivo effects of these antisera were tested for their ability to modulate the growth of P815 tumors in DBA/2 mice. It was found that the antiserum raised in syngeneic (DBA/2) but not allogeneic (C57BL/6) mice was able to significantly slow the rate of tumor growth and to prolong survival in treated mice. The antiserum was effective in this way only if it was administered early in the course of tumor growth. It was shown that this effect was not attributable to the presence in the serum of antibodies directed to antigens present on P815 cells, and it therefore appears to be due to interference with the function of T suppressor cells arising early in the immune response to the tumor cells.

Original languageEnglish (US)
Pages (from-to)134-139
Number of pages6
JournalCancer Immunology Immunotherapy
Volume13
Issue number2
DOIs
StatePublished - Aug 1982
Externally publishedYes

Fingerprint

Immunologic Suppressor Factors
Immune Sera
Neoplasms
Inbred DBA Mouse
Inbred C57BL Mouse
Growth
Cytotoxic T-Lymphocytes
Cell Extracts
Cell Membrane
Antigens
Antibodies

ASJC Scopus subject areas

  • Oncology
  • Immunology
  • Cancer Research

Cite this

Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor. / Maier, Tom; Levy, Julia G.

In: Cancer Immunology Immunotherapy, Vol. 13, No. 2, 08.1982, p. 134-139.

Research output: Contribution to journalArticle

@article{68b97a47746d4dbdb550cd65b37b4078,
title = "Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor",
abstract = "DBA/2 mice inoculated with either cells from the syngeneic P815 tumor or tumor cell membrane extracts develop T suppressor cells which suppress the in vitro generation of cytotoxic T lymphocytes with specificity for the tumor. A soluble suppressor factor with similar properties can be isolated from suppressor cell-enriched populations. It can be highly purified by appropriate immunoadsorption. Antisera to this suppressor factor raised in either DBA/2 or C57BL/6 mice can specifically absorb out suppressor factor and eliminate suppressor cells in the presence of complement. The in vivo effects of these antisera were tested for their ability to modulate the growth of P815 tumors in DBA/2 mice. It was found that the antiserum raised in syngeneic (DBA/2) but not allogeneic (C57BL/6) mice was able to significantly slow the rate of tumor growth and to prolong survival in treated mice. The antiserum was effective in this way only if it was administered early in the course of tumor growth. It was shown that this effect was not attributable to the presence in the serum of antibodies directed to antigens present on P815 cells, and it therefore appears to be due to interference with the function of T suppressor cells arising early in the immune response to the tumor cells.",
author = "Tom Maier and Levy, {Julia G.}",
year = "1982",
month = "8",
doi = "10.1007/BF00205314",
language = "English (US)",
volume = "13",
pages = "134--139",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "2",

}

TY - JOUR

T1 - Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor

AU - Maier, Tom

AU - Levy, Julia G.

PY - 1982/8

Y1 - 1982/8

N2 - DBA/2 mice inoculated with either cells from the syngeneic P815 tumor or tumor cell membrane extracts develop T suppressor cells which suppress the in vitro generation of cytotoxic T lymphocytes with specificity for the tumor. A soluble suppressor factor with similar properties can be isolated from suppressor cell-enriched populations. It can be highly purified by appropriate immunoadsorption. Antisera to this suppressor factor raised in either DBA/2 or C57BL/6 mice can specifically absorb out suppressor factor and eliminate suppressor cells in the presence of complement. The in vivo effects of these antisera were tested for their ability to modulate the growth of P815 tumors in DBA/2 mice. It was found that the antiserum raised in syngeneic (DBA/2) but not allogeneic (C57BL/6) mice was able to significantly slow the rate of tumor growth and to prolong survival in treated mice. The antiserum was effective in this way only if it was administered early in the course of tumor growth. It was shown that this effect was not attributable to the presence in the serum of antibodies directed to antigens present on P815 cells, and it therefore appears to be due to interference with the function of T suppressor cells arising early in the immune response to the tumor cells.

AB - DBA/2 mice inoculated with either cells from the syngeneic P815 tumor or tumor cell membrane extracts develop T suppressor cells which suppress the in vitro generation of cytotoxic T lymphocytes with specificity for the tumor. A soluble suppressor factor with similar properties can be isolated from suppressor cell-enriched populations. It can be highly purified by appropriate immunoadsorption. Antisera to this suppressor factor raised in either DBA/2 or C57BL/6 mice can specifically absorb out suppressor factor and eliminate suppressor cells in the presence of complement. The in vivo effects of these antisera were tested for their ability to modulate the growth of P815 tumors in DBA/2 mice. It was found that the antiserum raised in syngeneic (DBA/2) but not allogeneic (C57BL/6) mice was able to significantly slow the rate of tumor growth and to prolong survival in treated mice. The antiserum was effective in this way only if it was administered early in the course of tumor growth. It was shown that this effect was not attributable to the presence in the serum of antibodies directed to antigens present on P815 cells, and it therefore appears to be due to interference with the function of T suppressor cells arising early in the immune response to the tumor cells.

UR - http://www.scopus.com/inward/record.url?scp=0019974786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019974786&partnerID=8YFLogxK

U2 - 10.1007/BF00205314

DO - 10.1007/BF00205314

M3 - Article

C2 - 6819080

AN - SCOPUS:0019974786

VL - 13

SP - 134

EP - 139

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 2

ER -